These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 21147765)

  • 1. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.
    Sorenmo KU; Rasotto R; Zappulli V; Goldschmidt MH
    Vet Pathol; 2011 Jan; 48(1):85-97. PubMed ID: 21147765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological prognostic factors in canine mammary tumors.
    Pérez Alenza MD; Peña L; Nieto AI; Castaño M
    Ann Ist Super Sanita; 1997; 33(4):581-5. PubMed ID: 9616968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The search for suitable prognostic markers for canine mammary tumors: A promising outlook.
    Zaidan Dagli ML
    Vet J; 2008 Jul; 177(1):3-5. PubMed ID: 18054505
    [No Abstract]   [Full Text] [Related]  

  • 4. Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases.
    Ressel L; Millanta F; Poli A
    J Comp Pathol; 2011 May; 144(4):303-7. PubMed ID: 20961557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
    Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
    Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
    Pereira PD; Lopes CC; Matos AJ; Cortez PP; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2010; 143(2-3):87-93. PubMed ID: 20153868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the diagnosis and treatment of canine mammary tumours: Immunohistochemical markers as prognostic tools.
    Morris JS
    Vet J; 2010 Apr; 184(1):3-4. PubMed ID: 19713137
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
    Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA
    J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of canine and human breast cancer.
    Owen LN
    Invest Cell Pathol; 1979; 2(4):257-75. PubMed ID: 396282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
    Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
    Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p27 expression in canine mammary tumors and their metastases.
    Klopfleisch R; Schütze M; Gruber AD
    Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary cancer in the dog: a study of 120 cases.
    Mulligan RM
    Am J Vet Res; 1975 Sep; 36(9):1391-6. PubMed ID: 169716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
    de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
    Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
    Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors.
    Dias Pereira P; Lopes CC; Matos AJ; Pinto D; Gärtner F; Lopes C; Medeiros R
    Vet Pathol; 2008 Mar; 45(2):124-30. PubMed ID: 18424824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.